The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Open accessAbstract
SUMMARY Catabolic conditions like chronic kidney disease (CKD) cause loss of muscle mass by unclear mechanisms. In muscle biopsies from CKD patients, we found activated Stat3 (p-Stat3) and hypothesized that p-Stat3 initiates muscle wasting. We created mice with muscle-specific knockout (KO) that prevents activation of Stat3. In these mice, losses of body and muscle weights were suppressed in models of CKD or acute diabetes. A small molecule that inhibits Stat3 activation produced similar responses suggesting a potential for translation strategies. Using C/EBPδ KO mice and C2C12 myotubes with knockdown of C/EBPδ or myostatin, we determined that p-Stat3 initiates muscle wasting via C/EBPδ, stimulating myostatin, a negative muscle growth regulator. C/EBPδ KO also improved survival of CKD mice. We verified that p-Stat3, C/EBPδ and myostatin were increased in muscles of CKD patients. The pathway from p-Stat3 to C/EBPδ to myostatin and muscle wasting could identify therapeutic targets that prevent muscle wasting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., Franch, H., Guarnieri, G., Ikizler, T. A., Kaysen, G., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002585 · Cited by 2,000
Self-citationStitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“degradation via the ubiquitin-proteasome system (UPS) (Zhang et al., 2011; Lecker et al., 2004).”
Self-citationA nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,328
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Self-citationReversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 731
Self-citationThe Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions
Poli, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29279 · Cited by 677 · cited 1×
“C/EBPb or -d can stimulate intracellular signaling in hepatocytes or inflammatory cells (Poli, 1998; Akira et al., 1990; Alonzi et al., 1997) and in muscles of mice responding to an excess of glucocorticoids, the expression and binding activity of C/ EBPb and -d are increased (Penner et al.”
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
Immunologic function and survival in hemodialysis patients
Kimmel, P. L., Phillips, T. M., Simmens, S. J., Peterson, R. A., Weihs, K. L., Alleyne, S., Cruz, I., Yanovski, J. A., & Veis, J. H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00981.x · Cited by 512
Signaling mechanisms through gp130: A model of the cytokine system
Hirano, T., Nakajima, K., & Hibi, M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)80005-1 · Cited by 370
Price, S. R., Bailey, J. L., Wang, X., Jurkovitz, C., England, B. K., Ding, X., Phillips, L. S., & Mitch, W. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118968 · Cited by 349
Self-citationBonetto, A., Aydogdu, T., Kunzevitzky, N., Guttridge, D. C., Khuri, S., Koniaris, L. G., & Zimmers, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022538 · Cited by 348 · cited 2×
“Components of 20 signaling pathways were upregulated, including IL-6, Stat3, JAK-STAT, and SOCS3 complement and coagulation pathways (Bonetto et al., 2011).”
Lee, S. W., Dai, G., Hu, Z., Wang, X., Du, J., & Mitch, W. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000127211.86206.e1 · Cited by 325
Self-citationMay, R. C., Kelly, R. A., & Mitch, W. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112924 · Cited by 324
Self-citationZhang, L., Rajan, V., Lin, E., Hu, Z., Han, H. Q., Zhou, X., Song, Y., Min, H., Wang, X., Du, J., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-176917 · Cited by 316
Self-citationBradshaw, E. M., Raddassi, K., Elyaman, W., Orban, T., Gottlieb, P. A., Kent, S. C., & Hafler, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900576 · Cited by 297
Interleukin-6 Induces Skeletal Muscle Protein Breakdown in Rats
Goodman, M. N. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43695 · Cited by 296
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero, J. J., Chmielewski, M., Axelsson, J., Snaedal, S., Heimbürger, O., Bárány, P., Suliman, M. E., Lindholm, B., Stenvinkel, P., & Qureshi, A. R. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.04.007 · Cited by 292
Interleukin-6 and cachexia in ApcMin/+mice
Baltgalvis, K. A., Berger, F. G., Pena, M. M. O., Davis, J. M., Muga, S. J., & Carson, J. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00716.2007 · Cited by 280
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., & Tweardy, D. J. (2011) · Blood · doi:10.1182/blood-2010-04-280123 · Cited by 257
Self-citationIL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle Wasting
Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., & Mitch, W. E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060628 · Cited by 240
Self-citationRui, L., Fisher, T. L., Thomas, J., & White, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105332200 · Cited by 211
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects
Feldman, B. J., Streeper, R. S., Farese, R. V., & Yamamoto, K. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607501103 · Cited by 210
Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., & Bhasin, S. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1128 · Cited by 208
Hu, Z., Wang, H., Lee, I. H., Du, J., & Mitch, W. E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38770 · Cited by 205
Self-citationLalani, R., Bhasin, S., Byhower, F., Tarnuzzer, R., Grant, M., Shen, R., Asa, S., Ezzat, S., & Gonzalez-Cadavid, N. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670417 · Cited by 177
Sterneck, E., Paylor, R. E., Jackson-Lewis, V. R., Libbey, M., Przedborski, S., Tessarollo, L., Crawley, J. N., & Johnson, P. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10908 · Cited by 165
Inflammation and cachexia in chronic kidney disease
Cheung, W. W., Paik, K. H., & Mak, R. H. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1427-z · Cited by 162
Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
Xu, X., Kasembeli, M. M., Jiang, X., Tweardy, B. J., & Tweardy, D. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004783 · Cited by 141
Self-citationIL-1β Receptor Antagonist Reduces Inflammation in Hemodialysis Patients
Hung, A. M., Ellis, C. D., Shintani, A., Booker, C., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070760 · Cited by 121
Verzola, D., Procopio, V., Sofia, A., Villaggio, B., Tarroni, A., Bonanni, A., Mannucci, I., Cian, F. D., Gianetta, E., Saffioti, S., et al. (2011) · Kidney International · doi:10.1038/ki.2010.494 · Cited by 96
Self-citationWang, X. H., Zhang, L., Mitch, W. E., LeDoux, J. M., Hu, J., & Du, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041707 · Cited by 89
Self-citationC/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle
Penner, G. C., Gang, G., Sun, X., Wray, C. J., & Hasselgren, P. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00512.2001 · Cited by 88
Myśliwiec, M., Balcerska, A., Zorena, K., Myśliwska, J. M., Lipowski, P., & Raczyńska, K. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.011 · Cited by 77
Expression and activity of C/EBPβ and δ are upregulated by dexamethasone in skeletal muscle
Yang, H., Mammen, J. M. V., Wei, W., Menconi, M. J., Evenson, A. R., Fareed, M. U., Petkova, V., & Hasselgren, P.-O. J. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20278 · Cited by 70
Decreased resting energy expenditure in non-dialysed chronic kidney disease patients
Avesani, C. M., Draibe, S. A., Kamimura, M. A., Dalboni, M. A., Colugnati, F. A. B., & Cuppari, L. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh547 · Cited by 67
The Serum IL-6 Profile and Treg/Th17 Peripheral Cell Populations in Patients with Type 1 Diabetes
Ryba-Stanisławowska, M. E., Skrzypkowska, M. W., Myśliwska, J. M., & Myśliwiec, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/205284 · Cited by 52
Zhang, Y., Sif, S., & DeWille, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21356 · Cited by 51
Shelbaya, S., Amer, H., Seddik, S., Aa, A., Im, S., Mohamed, T. Y. H., & El Mosely, M. (2012) · PubMed · Cited by 48
Allen, D. L., Cleary, A. S., Hanson, A. M., Lindsay, S. F., & Reed, J. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2010 · Cited by 46
C/EBP? is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells
Sanford, D., & DeWille, J. W. (2004) · The Prostate · doi:10.1002/pros.20159 · Cited by 45
Alonzi, T., Gorgoni, B., Screpanti, I., Gulino, A., & Poli, V. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80035-6 · Cited by 36
The Jak-STAT Pathway Stimulated by Interleukin 6
Horvath, C. M. (2004) · Science s STKE · doi:10.1126/stke.2602004tr9 · Cited by 35
Foss‐Freitas, M. C., Foss, N. T., Donadi, E. A., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.027 · Cited by 29
Myśliwiec, M., Balcerska, A., Zorena, K., Myśliwska, J. M., Lipska-Ziętkiewicz, B. S., Wiśniewski, P., & Myśliwski, A. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.12.1421 · Cited by 15
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Mechanisms of muscle wasting in chronic kidney disease
Wang, X. H., & Mitch, W. E. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.112 · Cited by 616
Self-citationUrea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion
Weiner, I. D., Mitch, W. E., & Sands, J. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10311013 · Cited by 492
Self-citationSTAT3 signaling controls satellite cell expansion and skeletal muscle repair
Tierney, M. T., Aydogdu, T., Sala, D., Malecova, B., Gatto, S., Puri, P. L., Latella, L., & Sacco, A. (2014) · Nature Medicine · doi:10.1038/nm.3656 · Cited by 401
Skeletal muscle atrophy: From mechanisms to treatments
Yin, L., Li, N., Jia, W., Wang, N., Liang, M., Yang, X., & Du, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105807 · Cited by 396
Metadata
- Authors
- Zhang, L., Pan, J., Dong, Y., Tweardy, D. J., Dong, Y., Garibotto, G., & Mitch, W. E.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 18
- Issue
- 3
- Pages
- 368-379
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2037370931
- Cited by
- 263
- References
- 53
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.